NIPH Clinical Trials Search

Basic Information

Recruitment status	completed
Health condition(s) or Problem(s) studied
Date of first enrollment	27/03/2020
Target sample size	60
Countries of recruitment	Japan,North America,South America,Europe,null
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : INN of investigational material : eliglustat Therapeutic category code : 399 Agents affecting metabolism, n.e.c. Dosage and Administration for Investigational material : Generic name etc : INN of investigational material : imiglucerase Therapeutic category code : 399 Agents affecting metabolism, n.e.c. Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : - Therapeutic category code : Dosage and Administration for Investigational material :

Outcome(s)

Primary Outcome	pharmacokinetics pharmacokinetics safety
Secondary Outcome	efficacy efficacy efficacy efficacy efficacy efficacy efficacy efficacy

Key inclusion & exclusion criteria

Age minimum	>= 2age old
Age maximum	<= 17age old
Gender	Both
Include criteria
Exclude criteria